Announcements Trials
Browse Landscape

Phase

Phase 2 53Phase 3 35Phase 1 14Phase 1/2 3Phase 4 2Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Primary Breast Cancer 1Patient Acceptance of Health Care 1Non-small Cell Lung Cancer Metastatic 1Lung Neoplasms 1Lung Diseases 1

Interventions

Pemetrexed 10Cisplatin 9Erlotinib Hydrochloride 8Carboplatin 7icotinib 5Gefitinib 5Docetaxel 5endostar protein 3Zoledronic Acid 3Radiotherapy 3Paclitaxel 3Gemcitabine 3Endostatins 3Afatinib 3tislelizumab 2pembrolizumab 2osimertinib 2lorlatinib 2flurbiprofen axetil 2dexamethasone 21-phosphate 2atezolizumab 2Vinorelbine 2Surgical Procedures, Operative 2Saline Solution 2Nivolumab 2Drug Therapy 2Dexamethasone 2Chemoradiotherapy 2trametinib 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Non-Small-Cell Lung × Vinorelbine × Clear all
NCT01196078 2015-07-27

A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 4 Completed
114 enrolled 15 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02497118 2015-07-14

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Completed
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡